Hemp in Switzerland: terms, products and legal framework

Hemp covers very different uses. Swiss classification depends on total THC content and the product category, rather than the name on the packaging alone.

TL;DR: Total THC below 1% does not automatically make every use or product permissible. Legal classification, product quality and medical effectiveness are separate questions.

Separating hemp, cannabis and CBD

“Hemp” can refer to the plant, a raw material or a processed product. CBD, by contrast, identifies a particular compound. The terms are therefore not interchangeable. A general description of the plant cannot answer a specific product question.

First identify the subject: fibres, seeds or a cannabinoid-containing item? The appropriate legal and technical references can then be selected. A shared plant origin does not make these uses equivalent.

Reading the THC threshold correctly

FOPH describes hemp below 1% THC as outside the Narcotics Act. Cannabis at 1% and above falls within that framework. A value of exactly 1% must therefore not be described as below 1%.

That threshold is not a general approval. It answers a particular legal classification question without resolving every requirement for manufacturing, marketing or use. Medical applications and authorised scientific trials have their own conditions.

Product category still matters

Swissmedic’s implementation guide explains why cannabinoid products need assessment according to their category. “Contains CBD” cannot replace classification. A name such as “hemp oil” does not by itself establish the composition or legal intended use.

Check the full description, intended use and associated claims. A classification from another country does not automatically carry over to Switzerland either. Our legal overview brings together the Swiss questions to explore further.

Laboratory results do not establish medical effectiveness

An analysis can provide information about the sample examined. It cannot alone establish that a product treats a disease, suits every use or meets every legal requirement. Composition, permissibility and effectiveness each need appropriate evidence.

Check the link between report and batch, the testing date and the parameters measured. Without that connection, even a precise number is difficult to interpret. The laboratory guide explains which questions a report can answer and which remain open.

Checking the basis of market claims

Shop counts, market shares and turnover estimates need a named source, time period and definition. Without them, it is unclear what was counted. Repeating an unsupported estimate does not make it reliable.

The same applies to descriptions such as “Europe’s most liberal market”: the rules and countries compared would need to be specified. This overview therefore uses no unconfirmed market totals or rankings. When reading an announcement, separate measured data, estimates and political proposals.

FAQ

Is every product below 1% THC automatically permitted?

No. The threshold cannot replace assessment of other rules applying to the product category.

Are hemp oil and CBD oil the same?

The name alone does not establish that. The actual composition and product description matter.

Does a laboratory report prove medical effectiveness?

No. A composition report is not clinical evidence of effectiveness.

Does this page give a confirmed Swiss market size?

No. Without solid data and a clear definition, we give no blanket turnover or shop count.

Sources & references